Source: Web Search Publisher: FAES FARMA, S.A., C/Máximo Aguirre, 14, 48940 Leioa (Bizkaia), Spain
Mecolzine 500 mg gastro-resistant tablets.
| Pharmaceutical Form |
|---|
|
Gastro-resistant tablets. Oblong tablets of 17.9 mm of length and 8.3 mm of diameter, with homogeneous gastro-resistant orange coloured coating. |
Each tablet of Mecolzine 500 mg gastro-resistant tablets contains 500 mg of mesalazine.
Excipient with known effect: Each tablet contains 2.13 mmols of sodium (49 mg).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Mesalazine |
Mesalazine is an aminosalicylate. The mechanism of action of mesalazine is not fully understood, but appears to have a topical anti-inflammatory effect on the colonic epithelial cells. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase and lipoxygenase pathways, is increased in patients with chronic inflammatory bowel disease, and it is possible that mesalazine diminishes inflammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon. |
| List of Excipients |
|---|
|
Sodium carbonate, anhydrous |
Aluminium/Aluminium blister packed in cartons containing 100 tablets.
FAES FARMA, S.A., C/Máximo Aguirre, 14, 48940 – Leioa (Bizkaia), Spain
MA1278/00101
Date of first authorisation: 14/11/2019
| Drug | Countries | |
|---|---|---|
| MECOLZINE | Cyprus, Ecuador, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
